VINICIUS AFONSO GOMES

Dr. VINICIUS AFONSO GOMES

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in Brazilian Journal of Physical Therapy
Verified
Journal Article
Closed access
MGMansueto Gomes-Neto
Mansueto Gomes-Neto
KAKatna de Oliveira Almeida
Katna de Oliveira Almeida
HCHelena França Correia
Helena França Correia
JSJuliana Costa Santos
Juliana Costa Santos
VGVINICIUS AFONSO GOMES
VINICIUS AFONSO GOMES
VCVitor Oliveira Carvalho
Vitor Oliveira Carvalho

Cássia Da Luz GoulartCássia Da Luz Goulart
Cássia Da Luz Goulart
GAGuilherme Peixoto Tinoco Areas
Guilherme Peixoto Tinoco Areas
MMMauricio Milani
Mauricio Milani
FBFernanda Facioli dos Reis Borges
Fernanda Facioli dos Reis Borges
JMJuliana Ribeiro Magalhães
Juliana Ribeiro Magalhães
FAFernando Almeida-Val
Fernando Almeida-Val
Aim: (I) to verify if there are sex differences in respiratory function, respiratory muscle strength, and effort limitation in individuals recovered from severe acute COVID-19 30 months after the initial infection, and (II) to evaluate the influence of length of stay on cardiorespiratory capacity among men and women. Methods: Cross-sectional observational multicentric study with participants from five Brazilian states (São Paulo, Amazonas, Minas Gerais, Bahia, and Brasília). We assessed lung function and respiratory muscle strength by maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP), and cardiorespiratory fitness by cardiopulmonary exercise test (CPET). Results: 86 individuals were stratified by sex (48 women and 38 men). Females had significantly longer hospitalization for acute COVID-19 (p < 0.05) and showed a marked reduction in MIP (cmH2O and % predicted). Regarding the CPET, women presented lower V˙O2% predicted, O2 pulse, and oxygen uptake efficiency slope (OUES, % predicted) (p < 0.05). In addition, women also had greater abnormal combinations between RER < 1.10, OUES < 80% predicted, VE/VVM < 15% [3 (6.2%)] and V˙O2% predicted < 80%, V˙E/V˙CO2 slope and V˙O2/workload < 8.4 mL/min/W [8 (17%)]. The regression analysis showed a significant influence of age, length of hospitalization (< and >10 days), and FEV1/FVC (%) on the V˙O2 peak (mL·kg−1·min−1). Secondarily, we found that women hospitalized for more than 10 days had worse O2 pulse (p = 0.03), OUES % predicted (p < 0.001), and worse V˙O2% predicted (p < 0.009). Conclusion: Women exhibited more pronounced impairments in several key indicators of cardiopulmonary function 30 months post-infection.

10 September 2020 in Revista Pesquisa em Fisioterapia
Verified
Journal Article
Open access
PDF file
RMRenata Ferreira de Moura
Renata Ferreira de Moura
ASAlan Carlos Nery dos Santos
Alan Carlos Nery dos Santos
RBRamon Martins Barbosa
Ramon Martins Barbosa
BMBruno Prata Martinez
Bruno Prata Martinez
VGVINICIUS AFONSO GOMES
VINICIUS AFONSO GOMES
INTRODUÇÃO: Um curto período de hospitalização, se acompanhado de imobilidade, pode ser capaz de promover declínio das funções musculoesqueléticas, gerando impacto negativo na funcionalidade e qualidade de vida. Com isso, tem-se tornado cada vez mais comum a adoção de estratégias terapêuticas como o uso da plataforma vibratória (PV). OBJETIVO: Sistematizar evidências sobre a funcionalidade e a segurança da aplicação da PV em pacientes adultos hospitalizados. MÉTODOS: Revisão sistemática, registrada na PROSPERO com código CRD42019119672. Desenvolvida nas bases: LILACS, SciELO, MedLine/PubMed, EBSCOhost e PEDro. Descritores e palavras-chave: “Whole body vibration”, “Intensive Care Units”, “hospitalization”, “muscle strenght”, e “functional capacity”. Incluídos estudos que analisaram os efeitos e a segurança da aplicação da PV em pacientes adultos hospitalizados. A qualidade metodológica foi avaliada através da escala Downs and Black. RESULTADOS: Incluídos 2 estudos, um ensaio clínico randomizado e outro estudo de intervenção controlado. A amostra variou entre 24 e 40 sujeitos, de ambos os sexos, média de idade 52±4 anos, com diagnóstico de DPOC e condições variadas. Houve uma melhora na distância percorrida no teste de caminhada de seis minutos e diminuição no tempo do teste de sentar e levantar, aumento dos níveis de irisina e melhora na qualidade de vida, em relação aos parâmetros dos sinais vitais não teve alterações significativas. O escore metodológico foi em média 16. CONCLUSÃO: Os resultados indicam que a PV parece ser viável e segura, podendo trazer efeitos favoráveis na funcionalidade para o tratamento em pacientes adultos hospitalizados, sendo uma alternativa para a reabilitação de forma precoce.

17 April 2018 in Revista Pesquisa em Fisioterapia
Verified
Journal Article
Open access
JPJefferson Petto
Jefferson Petto
MSMarvyn de Santana Do Sacramento
Marvyn de Santana Do Sacramento
VGVINICIUS AFONSO GOMES
VINICIUS AFONSO GOMES
AAAndré Lemos de Souza Andrade
André Lemos de Souza Andrade
ASAlan Carlos Nery Dos Santos
Alan Carlos Nery Dos Santos
ALAna Marice Teixeira Ladeia
Ana Marice Teixeira Ladeia
INTRODUCTION: Although the reductive effect of a single physical exercise (PE) session on postprandial lipemia (PPL) is controversial, studies indicate that caloric expenditure is the main determinant of PPL reduction. OBJECTIVE: Test the hypothesis that a PE session based on caloric expenditure modifies PPL. METHODS: This is a prospective controlled intervention study, including a cohort of 18 men with average age of 22 ± 1.3 years and BMI of 21 ± 4.2 kg/m². All were irregularly active students, with fasting triglyceride (TG) values of less than or equal to 150mg/dL. They were submitted to two PPL tests: Basal (PPLB) and Exercise (PPLE). Blood samples were collected at time 0 (fasting) and after ingestion of a lipid compound (25g) at 180 and 240 minutes for TG dosing. In the PPLE test, a PE session on treadmill was applied shortly after the collection at 120 minutes, achieving an energy expenditure of 500kcal. STATISTICS: The medians of the variation (delta) between the TG values between fasting and 120min (?1), fasting and 240min (?2) and between 120 and 240min (?3) were compared. The bi-directional Wilcoxon test was used to compare deltas. RESULTS: The TG medians of ?1 respectively for PPLB and PPLE were 63 Vs.60 (p=0.95); ?2 102 Vs. 25 (p=0.02) and ?3 32 Vs. -10 (p<0.01). CONCLUSION: In this study, a physical exercise session based on caloric expenditure of 500kcal, after lipid intake, reduced the PPL peak in healthy youngsters.

7 April 2020 in Revista Brasileira de Fisiologia do Exercício
Verified
Journal Article
Open access
PDF file
VGVINICIUS AFONSO GOMES
VINICIUS AFONSO GOMES
Although it is best known for damage to the respiratory system, today we know that the new coronavirus (COVID-19) can also compromise the heart [1]. This fact started to gain strength when a retrospective study pointed out that 33% of deaths in these cases were attributed to cardiorespiratory failure, and 7% to isolated heart failure [2]. A report of a previously healthy woman who developed acute myopericarditis with systolic dysfunction during a COVID-19 condition, drew attention. In this case, it was possible to detect systemic inflammatory responses associated with markers of myocardial injury, such as elevated serum levels of highly sensitive troponin T and creatine kinase-MB. Furthermore, abnormalities in ventricular contraction were found, without any sign of obstruction of the acute coronary flow [3]. Despite the strong evidence, there is still no proof of the presence of the virus within the myocardium, however the occurrence of direct and indirect cardiac lesions attributed to it is plausible. Indirect injuries can be caused by cardiac overload resulting from hypoxemic respiratory failure and systemic inflammation. Whereas direct lesions would be caused by successful tissue infection resulting in the death of cardiomyocytes [4]. Another fact that suggests direct cardiac injury by COVID-19 was the presence of an inflammatory infiltrate of mononucleated cells found in autopsies in cardiac tissue [5]. In 2009, an outbreak caused by a variation of the coronavirus led researchers to investigate the presence of the viral genome in cardiac autopsies. Through the real-time polymerase chain reaction (qPCR), it was possible to find the genome in 35% of patients who died of acute respiratory syndrome [6]. This shows that it is possible to expect similar behavior in cases of COVID-19, as the genomes of both viruses are extremely similar [7]. Previous knowledge states that viral respiratory infections can be the “trigger” for adverse effects of the heart [8]. In the case of arrhythmias, its manifestation can be observed in several ways, ranging from “simple” isolated premature ventricular contractions, to the successful ventricular fibrillation of asystole [9]. Regardless of the condition that generates arrhythmias, it is known that episodes of hypoxemia, sympathetic hyperactivity and pro-inflammatory effects, can make them more frequent [8,9]. If in respiratory infections, healthy hearts can develop arrhythmias, what to expect from those with some affection already installed? The additional inflammation that is generated on the atheromatous plaque, together with the increased demand for oxygen and the reduction of its availability, increase the chances of myocardial infarction [10,11]. The clot formed in cases where the plaque ruptures limits the passage of blood, which causes ischemia and cardiac dysfunction [12]. Still about ischemia, it is necessary to remember that pericytes are contractile, branched cells that have an important role in reducing the permeability of blood vessels [13]. Infectious conditions can promote lesions of these structures, thus causing ruptures of the microcirculation, with subsequent myocardial ischemia [4]. It is true that this process is still speculative, lacking studies that can confirm its hypothesis. The chances of heart failure decompensation in a COVID-19 infection are high. Its causes are also among those that trigger arrhythmias and infarction, especially myocarditis [8]. The risk of a heart with previous dysfunction deteriorating becomes greater when trying to compensate someone's respiratory system with all the consequences of a systemic inflammation [7]. Despite the relevance of decompensating heart failure, there is another scenario that is even more worrying. Retrospective cohorts have shown that signs of cardiac injury, such as increased levels of troponin at the onset of the disease, are associated with a worse prognosis [2,14]. In the study by Guo et al. [7] the direct relationship between troponin T and the levels of highly sensitive C-reactive protein (CRP) was proven, an important inflammatory marker that reinforces the link between inflammation and myocardial injury. This fact should not go unnoticed, as the risk of death in cases of myocardial injury exceeds that of factors such as age, presence of diabetes mellitus, previous chronic lung and heart disease [7,15]. In short, the heart can be greatly affected in cases of COVID-19, contributing to a significant portion of cases of morbidity and mortality. The worst outcomes seem to be associated with those cases where the infectious process directly affects the heart, increasing the levels of troponin T and CRP. We must emphasize that there are several consequences, including arrhythmias, infarction and heart failure decompensation, triggered mainly by the exacerbated inflammatory response and myocarditis.

2 February 2023 in Revista Brasileira de Fisiologia do Exercício
Verified
Journal Article
Open access
PDF file
KSKezia Natália Oliveira Santos
Kezia Natália Oliveira Santos
LSLais Oliveira Santos
Lais Oliveira Santos
RMRenata Ferreira de Moura
Renata Ferreira de Moura
RBRamon Martins Barbosa
Ramon Martins Barbosa
RFRodrigo Freitas Fontes
Rodrigo Freitas Fontes
VGVINICIUS AFONSO GOMES
VINICIUS AFONSO GOMES
Introdução: A fibrilação atrial (FA) é uma das arritmias supraventriculares mais comuns. A ablação cardíaca representa uma das formas terapêuticas, pois evita as recorrências da FA e os efeitos colaterais das medicações. Como adjuvante a ablação, a reabilitação cardiovascular pode potencializar a capacidade de exercício e a qualidade de vida. Objetivo: Investigar os efeitos da reabilitação cardiovascular na capacidade de exercício e qualidade de vida de indivíduos com fibrilação atrial submetidos a cirurgia de ablação cardíaca. Métodos: Revisão sistemática conforme a PRISMA, realizada por autores independentes nas bases de dados Pubmed, BVS, PEDro e SciELO, no período de fevereiro a abril de 2020. Cruzamento dos dados realizado pelos descritores e palavra-chave: “atrial fibrillation”, “exercise” e “ablation”, utilizando operador booleano “AND”. Foram incluídos ensaios clínicos, sem restrição quanto ao tempo de publicação ou ao idioma. A qualidade metodológica dos estudos foi avaliada através da escala PEDro. Resultados: 526 artigos foram rastreados, contudo apenas 3 foram elegíveis. O tamanho amostral variou de 24 a 210, totalizando 302 indivíduos. A reabilitação cardiovascular manteve-se em intensidade moderada, com exercícios de resistência e aeróbicos, no período de 2 a 6 meses. Os artigos elegíveis apresentaram qualidade metodológica moderada. Conclusão: Os estudos mostraram melhora significativa da capacidade de exercício e da qualidade de vida refletida no aumento do VO2máx, no melhor desempenho no teste de caminhada de 6 minutos e na melhora dos componentes de saúde física e saúde mental.